Evidence map›Paper›PMID 26829319›Full record

ArticleNature biotechnology2016

Haplotyping germline and cancer genomes with high-throughput linked-read sequencing.

Grace X Y Zheng, Billy T Lau, Michael Schnall-Levin, Mirna Jarosz, John M Bell, Christopher M Hindson, Sofia Kyriazopoulou-Panagiotopoulou, Donald A Masquelier, Landon Merrill, Jessica M Terry and 48 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 396 papers.

0numbers the graph read from it
0cells of the map it votes in
396citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

396 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Genome assemblies of IndianNAR genomics and bioinformatics · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. A complete diploid human genome benchmark for personalized genomics.bioRxiv : the preprint server for biology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Review

336 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

58 authors.

Grace X Y Zheng10X Genomics, Pleasanton, California, USA.
Billy T LauStanford Genome Technology Center, Stanford University, Palo Alto, California, USA.
Michael Schnall-Levin10X Genomics, Pleasanton, California, USA.
Mirna Jarosz10X Genomics, Pleasanton, California, USA.
John M BellStanford Genome Technology Center, Stanford University, Palo Alto, California, USA.
Christopher M Hindson10X Genomics, Pleasanton, California, USA.
Sofia Kyriazopoulou-Panagiotopoulou10X Genomics, Pleasanton, California, USA.
Donald A Masquelier10X Genomics, Pleasanton, California, USA.
Landon Merrill10X Genomics, Pleasanton, California, USA.
Jessica M Terry10X Genomics, Pleasanton, California, USA.
Patrice A Mudivarti10X Genomics, Pleasanton, California, USA.
Paul W Wyatt10X Genomics, Pleasanton, California, USA.
Rajiv Bharadwaj10X Genomics, Pleasanton, California, USA.
Anthony J Makarewicz10X Genomics, Pleasanton, California, USA.
Yuan Li10X Genomics, Pleasanton, California, USA.
Phillip Belgrader10X Genomics, Pleasanton, California, USA.
Andrew D Price10X Genomics, Pleasanton, California, USA.
Adam J Lowe10X Genomics, Pleasanton, California, USA.
Patrick Marks10X Genomics, Pleasanton, California, USA.ORCID http://orcid.org/0000-0002-3231-7163
Gerard M Vurens10X Genomics, Pleasanton, California, USA.
Paul Hardenbol10X Genomics, Pleasanton, California, USA.
Luz Montesclaros10X Genomics, Pleasanton, California, USA.
Melissa Luo10X Genomics, Pleasanton, California, USA.
Lawrence Greenfield10X Genomics, Pleasanton, California, USA.
Alexander Wong10X Genomics, Pleasanton, California, USA.
David E Birch10X Genomics, Pleasanton, California, USA.
Steven W Short10X Genomics, Pleasanton, California, USA.
Keith P Bjornson10X Genomics, Pleasanton, California, USA.
Pranav Patel10X Genomics, Pleasanton, California, USA.
Erik S HopmansStanford Genome Technology Center, Stanford University, Palo Alto, California, USA.
Christina WoodDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Sukhvinder Kaur10X Genomics, Pleasanton, California, USA.
Glenn K Lockwood10X Genomics, Pleasanton, California, USA.
David Stafford10X Genomics, Pleasanton, California, USA.
Joshua P Delaney10X Genomics, Pleasanton, California, USA.
Indira Wu10X Genomics, Pleasanton, California, USA.
Heather S Ordonez10X Genomics, Pleasanton, California, USA.
Susan M GrimesStanford Genome Technology Center, Stanford University, Palo Alto, California, USA.
Stephanie GreerDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Josephine Y Lee10X Genomics, Pleasanton, California, USA.
Kamila Belhocine10X Genomics, Pleasanton, California, USA.
Kristina M Giorda10X Genomics, Pleasanton, California, USA.
William H Heaton10X Genomics, Pleasanton, California, USA.
Geoffrey P McDermott10X Genomics, Pleasanton, California, USA.
Zachary W Bent10X Genomics, Pleasanton, California, USA.
Francesca Meschi10X Genomics, Pleasanton, California, USA.
Nikola O Kondov10X Genomics, Pleasanton, California, USA.
Ryan Wilson10X Genomics, Pleasanton, California, USA.
Jorge A Bernate10X Genomics, Pleasanton, California, USA.
Shawn Gauby10X Genomics, Pleasanton, California, USA.
Alex Kindwall10X Genomics, Pleasanton, California, USA.
Clara Bermejo10X Genomics, Pleasanton, California, USA.
Adrian N Fehr10X Genomics, Pleasanton, California, USA.
Adrian Chan10X Genomics, Pleasanton, California, USA.
Serge Saxonov10X Genomics, Pleasanton, California, USA.
Kevin D Ness10X Genomics, Pleasanton, California, USA.
Benjamin J Hindson10X Genomics, Pleasanton, California, USA.
Hanlee P JiStanford Genome Technology Center, Stanford University, Palo Alto, California, USA.

Funding

WHOLE YEAST GENOME TRANSCRIPTIONAL AND FUNCTIONAL GENE MAPS--A FEASIBILITY STUDYP01HG000205 · NHGRI · STANFORD UNIVERSITY · PI DAVIS, RONALD WAYNE, HOWE, ROGER THOMAS · 1990 to 2016
$120.9M
Statistical Models for Genome Sequencing and AssociationR01HG006137 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI JI, HANLEE P, ZHANG, NANCY R · 2011 to 2022
$4.3M
Integrated Genomic Discovery and Functional Validation of Colorectal Cancer LociU01CA151920 · NCI · STANFORD UNIVERSITY · PI JI, HANLEE P, KUO, CALVIN J · 2011 to 2015
$2.6M
Oligonucleotide-Selective Sequencing for integrated and rapid cancer genome analyR33CA174575 · NCI · STANFORD UNIVERSITY · PI JI, HANLEE P · 2013 to 2015
$1.1M
Howard Hughes Medical InstituteNCI NIH HHS R33 CA174575NCI NIH HHS R33CA174575NCI NIH HHS U01 CA151920NHGRI NIH HHS P01 HG000205NHGRI NIH HHS P01HG000205NHGRI NIH HHS R01 HG006137NHGRI NIH HHS R01HG006137
6 · The paper itself

Abstract

Haplotyping of human chromosomes is a prerequisite for cataloguing the full repertoire of genetic variation. We present a microfluidics-based, linked-read sequencing technology that can phase and haplotype germline and cancer genomes using nanograms of input DNA. This high-throughput platform prepares barcoded libraries for short-read sequencing and computationally reconstructs long-range haplotype and structural variant information. We generate haplotype blocks in a nuclear trio that are concordant with expected inheritance patterns and phase a set of structural variants. We also resolve the structure of the EML4-ALK gene fusion in the NCI-H2228 cancer cell line using phased exome sequencing. Finally, we assign genetic aberrations to specific megabase-scale haplotypes generated from whole-genome sequencing of a primary colorectal adenocarcinoma. This approach resolves haplotype information using up to 100 times less genomic DNA than some methods and enables the accurate detection of structural variants.

Indexed as

DNAGenome, HumanGenomic Structural VariationGerm CellsHaplotypesHigh-Throughput Nucleotide SequencingHumansNeoplasmsNucleic Acid ConformationOncogene Proteins, FusionPolymorphism, Single NucleotideSequence Analysis, DNADNAEML4-ALK fusion protein, humanOncogene Proteins, Fusion

Identifiers

PMID26829319
PMCPMC4786454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.